Recent keywords
Below is a selection of the most prominant keywords that appear within the latest issue of SPIN.

Click the keywords to view the articles that contain these keywords. The larger the keyword, the more articles contain that keyword in our current issue.

Access to medicines
USA grapples with high drug costs
A number of recent cases of large, sudden increases to the costs of specific drugs has focused public attention on the pricing practices of big pharmaceutical companies in the USA. A 'Lancet' article describes the various perspectives on the issue heard at a recent 'pharmaceutical forum' hosted by the US Department of Health and Human Services, and the response of the Pharmaceutical Research and Manufacturers of America (PhRMA), the US trade association of brand name drug makers.

The Lancet    Vol.386  Issue.10009  - 28 November 2015 p.2127
  See Also:
Economist    Vol.417  - 28 November 2015 p.69-70
Brazilian courts tussle over unproven cancer treatment
A news article and accompanying editorial examine the recent controversy in Brazil over access to a new cancer drug called phosphoethanolamine, which has shown some promise but which is only at the very early stages of research. The editorial argues that the debate risks offering false hope to patients about the potential effectiveness of the drug, which has not been evaluated in any human trials.

Nature    Vol.527  Issue.7579  - 26 November 2015 p.420-421, 410
Gibbs Building, 215 Euston Road, London NW1 2BE, UK T:+44 (0)20 7611 8888